$9.220
-0.167 (-1.81%)收盘时
PIII 资讯
PIII 事件
Sees FY26 Adjusted EBITDA of $80M-$110M
Sees FY26 adjusted EBITDA $80M-$110M.
P3 Reports Q2 Revenue of $386.38M, Beating Expectations
Reports Q2 revenue $386.38M, consensus $377.95M. "Q2 demonstrates that the business is now executing according to our plan. We delivered $54 million of adjusted EBITDA, with the core business driving improved profitability quarter over quarter. Our results reflect the structural improvements now embedded across our contracts, our network, and our operating model, the work I outlined at the onset of my tenure. That strength gives us the confidence to raise our full-year 2026 adjusted EBITDA outlook and to enter the second half focused on execution," said Dr. Aric Coffman, CEO of P3.
P3 Health Partners Inc Trading Resumes
P3 Health Partners Inc trading resumes
P3 Health Partners Inc Trading Halted Due to Volatility
P3 Health Partners Inc trading halted, volatility trading pause
P3 Reports Q1 Revenue of $386M, Raises 2026 Adjusted EBITDA Outlook to $40M
Reports Q1 revenue $386M vs $373M last year. "Q1 represents a meaningful turning point for the business. The $26 million of adjusted EBITDA we delivered this quarter reflects the cumulative impact of two years of deliberate work, including contract restructuring, network concentration, and operational redesign. Based on the strength of Q1 and our confidence in the underlying trajectory, we are raising our full-year 2026 adjusted EBITDA outlook to a midpoint of $40 million," said Dr. Aric Coffman, CEO of P3.
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。





